Antitumor Effects of Self-Assembling Peptide-Emodin in situ Hydrogels in vitro and in vivo

References

• Zhao H, Yan G, Zheng L, et al. STIM1 is a metabolic checkpoint regulating the invasion and metastasis of hepatocellular carcinoma. Theranostics. 2020;10(14):6483–6499. doi:10.7150/thno.44025
   PubMedGoogle Scholar
• Ho YJ, Yeh CK. Concurrent anti-vascular therapy and chemotherapy in solid tumors using drug-loaded acoustic nanodroplet vaporization. Acta Biomater. 2017;49:472–485. doi:10.1016/j.actbio.2016.11.018
   PubMed Web of Science ®Google Scholar
• Xiao J, Zhou J, Liang L, et al. Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer. J BUON. 2019;24(3):967–974.
   PubMedGoogle Scholar
• Yang Z, Dai Y, Shan L, et al. Tumour microenvironment-responsive semiconducting polymer-based self-assembly nanotheranostics. Nanoscale Horiz. 2019;4(2):426–433. doi:10.1039/C8NH00307F
   PubMed Web of Science ®Google Scholar
• Khaliq NU, Oh KS, Sandra FC, et al. Assembly of polymer micelles through the sol-gel transition for effective cancer therapy. J Control Release. 2017;255:258–269. doi:10.1016/j.jconrel.2017.04.039
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang F, Yu G, et al. Zwitterionic-to-cationic charge conversion polyprodrug nanomedicine for enhanced drug delivery. Theranostics. 2020;10(15):6629–6637. doi:10.7150/thno.47849
   PubMedGoogle Scholar
• Xu Y, Zhai X, Su P, et al. Highly stable semiconducting polymer nanoparticles for multi-responsive chemo/photothermal combined cancer therapy. Theranostics. 2020;10(13):5966–5978. doi:10.7150/thno.43090
   PubMedGoogle Scholar
• Zou G, Zhang X, Wang L, et al. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Theranostics. 2020;10(15):6839–6853. doi:10.7150/thno.43622
   PubMed Web of Science ®Google Scholar
• Ahn SM, Kim HN, Yu RK, et al. Emodin from polygonum multiflorum, ameliorates oxidative toxicity in HT22 cells and deficits in photothrombotic ischemia. J Ethnopharmacol. 2016;188:13–20. doi:10.1016/j.jep.2016.04.058
   PubMed Web of Science ®Google Scholar
• Huang J, Gong W, Chen Z, et al. Emodin self-emulsifying platform ameliorates the expression of FN, ICAM-1 and TGF-β1 in AGEs-induced glomerular mesangial cells by promoting absorption. Eur J Pharm Sci. 2016;99:128–136. doi:10.1016/j.ejps.2016.12.012
   PubMedGoogle Scholar
• Ma YS, Weng SW, Lin MW, et al. Antitumor effects of emodin on LS1034 human colon cancer cells in vitro and in vivo: roles of apoptotic cell death and LS1034 tumor xenografts model. Food Chem Toxicol. 2012;50(5):1271–1278. doi:10.1016/j.fct.2012.01.033
   PubMed Web of Science ®Google Scholar
• Haque E, Kamil M, Irfan S, et al. Blocking mutation independent p53 aggregation by emodin modulates autophagic cell death pathway in lung cancer. Int J Biochem Cell Biol. 2018;96:90–95. doi:10.1016/j.biocel.2018.01.014
   PubMed Web of Science ®Google Scholar
• Zhang L, He D, Li K, et al. Emodin targets mitochondrial cyclophilin D to induce apoptosis in HepG2 cells. Biomed Pharmacother. 2017;90:222–228. doi:10.1016/j.biopha.2017.03.046
   PubMed Web of Science ®Google Scholar
• Iwanowycz S, Wang J, Hodge J, et al. Emodin inhibits breast cancer growth by blocking the tumor-promoting feedforward loop between cancer cells and macrophages. Mol Cancer Ther. 2016;15(8):1931–1942. doi:10.1158/1535-7163.MCT-15-0987
   PubMed Web of Science ®Google Scholar
• Lu J, Xu Y, Zhao Z, et al. Emodin suppresses proliferation, migration and invasion in ovarian cancer cells by down regulating ILK in vitro and in vivo. Oncotarget Ther. 2017;10:3579–3589. doi:10.2147/OTT.S138217
   PubMed Web of Science ®Google Scholar
• Tu Y, Wu Z, Tan B, et al. Emodin: its role in prostate cancer-associated inflammation (Review). Oncol Rep. 2019;42:1259–1271. doi:10.3892/or.2019.7264
   PubMed Web of Science ®Google Scholar
• Park B, Yoon W, Yun J, et al. Emodin-nicotinamide (1:2) cocrystal identified by thermal screening to improve emodin solubility. Int J Pharm. 2019;557:26–35. doi:10.1016/j.ijpharm.2018.12.027
   PubMedGoogle Scholar
• Fu M, Tang W, Liu JJ, et al. Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer. J Drug Target. 2020;28(3):245–258. doi:10.1080/1061186X.2019.1656725
   PubMed Web of Science ®Google Scholar
• Song Y, Sheng Z, Xu Y, et al. Magnetic liposomal emodin composite with enhanced killing efficiency against breast cancer. Biomater Sci. 2019;7(3):867–875. doi:10.1039/c8bm01530a
   PubMed Web of Science ®Google Scholar
• Yang Z, Xu H, Zhao X. Designer self‐assembling peptide hydrogels to engineer 3D cell microenvironments for cell constructs formation and precise oncology remodeling in ovarian cancer. Adv Sci (Weinh). 2020;7(9):1903718. doi:10.1002/advs.201903718
   PubMedGoogle Scholar
• Karavasili C, Andreadis DA, Katsamenis OL, et al. Synergistic antitumor potency of a self-assembling peptide hydrogel for the local co-delivery of doxorubicin and curcumin in the treatment of head and neck cancer. Mol Pharm. 2019;16(6):2326–2341. doi:10.1021/acs.molpharmaceut.8b01221
   PubMedGoogle Scholar
• Song X, Zhang Z, Zhu J, et al. Thermoresponsive hydrogel induced by dual supramolecular assemblies and its controlled release property for enhanced anticancer drug delivery. Biomacromolecules. 2020;21(4):1516–1527. doi:10.1021/acs.biomac.0c00077
   PubMedGoogle Scholar
• Kumar S, Bajaj A. Advances in self-assembled injectable hydrogels for cancer therapy. Biomater Sci. 2020;8(8):2055–2073. doi:10.1039/d0bm00146e
   PubMedGoogle Scholar
• Luo J, Wu Z, Lu Y, et al. Intraperitoneal administration of biocompatible hyaluronic acid hydrogel containing multi-chemotherapeutic agents for treatment of colorectal peritoneal carcinomatosis. Int J Biol Macromol. 2020;152:718–726. doi:10.1016/j.ijbiomac.2020.02.326
   PubMed Web of Science ®Google Scholar
• Vigata M, Meinert C, Pahoff S, et al. Gelatin methacryloyl hydrogels control the localized delivery of albumin-bound paclitaxel. Polymers (Basel). 2020;12(2):501–521. doi:10.3390/polym12020501
   PubMedGoogle Scholar
• Wu C, Liu J, Zhai Z, et al. Double-crosslinked nanocomposite hydrogels for temporal control of drug dosing in combination therapy. Acta Biomater. 2020;106:278–288. doi:10.1016/j.actbio.2020.02.021
   PubMed Web of Science ®Google Scholar
• Peng F, Zhang W, Qiu F. Self-assembling peptides in current nanomedicine: versatile nanomaterials for drug delivery. Curr Med Chem. 2020;27(29):4855–4881. doi:10.2174/0929867326666190712154021
   PubMedGoogle Scholar
• Morsi N, Ghorab D, Refai H, et al. Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery. Int J Pharm. 2016;506:57–67. doi:10.1016/j.ijpharm.2016.04.021
   PubMed Web of Science ®Google Scholar
• Chu K, Chen L, Xu W, et al. Preparation of a paeonol-containing temperature-sensitive in situ gel and its preliminary efficacy on allergic rhinitis. Int J Mol Sci. 2013;14(3):6499–6515. doi:10.3390/ijms14036499
   PubMedGoogle Scholar
• Wei W, Li H, Yin C, et al. Research progress in the application of in situ hydrogel system in tumor treatment. Drug Deliv. 2020;27(1):460–468. doi:10.1080/10717544.2020.1739171
   PubMed Web of Science ®Google Scholar
• Lammi C, Bollati C, Gelain F, et al. Enhancement of the stability and anti-DPPIV activity of hempseed hydrolysates through self-assembling peptide-based hydrogels. Front Chem. 2019;6:670. doi:10.3389/fchem.2018.00670
   PubMedGoogle Scholar
• Li X, Cao C, Wei P, et al. Self-assembly of amphiphilic peptides for recognizing high furin-expressing cancer cells. ACS Appl Mater Interfaces. 2019;11(13):12327–12334. doi:10.1021/acsami.9b01281
   PubMedGoogle Scholar
• Pan A, Wang Z, Chen B, et al. Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft. Drug Deliv. 2018;25(1):1495–1503. doi:10.1080/10717544.2018.1474971
   PubMed Web of Science ®Google Scholar
• Song Q, Zhang R, Lei L, et al. Self-assembly of succinated paclitaxel into supramolecular hydrogel for local cancer chemotherapy. J Biomed Nanotechnol. 2018;14(8):1471–1476. doi:10.1166/jbn.2018.2595
   PubMedGoogle Scholar
• Capanema NSV, Mansur AAP, Carvalho SM, et al. Bioengineered carboxymethyl cellulose-doxorubicin prodrug hydrogels for topical chemotherapy of melanoma skin cancer. Carbohydr Polym. 2018;195:401–412. doi:10.1016/j.carbpol.2018.04.105
   PubMed Web of Science ®Google Scholar
• Lee C, Lim K, Kim SS, et al. Near infrared light-responsive heat-emitting hemoglobin hydrogels for photothermal cancer therapy. Colloids Surf Biointerfaces. 2019;176:156–166. doi:10.1016/j.colsurfb.2018.12.070
   PubMed Web of Science ®Google Scholar
• Javanbakht S, Namazi H. Doxorubicin loaded carboxymethyl cellulose/graphene quantum dot nanocomposite hydrogel films as a potential anticancer drug delivery system. Mater Sci Eng C-Mater Biol Appl. 2018;87:50–59. doi:10.1016/j.msec.2018.02.010
   PubMed Web of Science ®Google Scholar
• Han TS, Hur K, Choi B, et al. Improvement of anti-cancer drug efficacy via thermosensitive hydrogel in peritoneal carcinomatosis in gastric cancer. Oncotarget. 2017;8(65):108848–108858. doi:10.18632/oncotarget.22312
   PubMedGoogle Scholar
• Pal VK, Jain R, Roy S. Tuning the supramolecular structure and function of collagen mimetic ionic complementary peptides via electrostatic interactions. Langmuir. 2020;364(4):1003–1013. doi:10.1021/acs.langmuir.9b02941
   Google Scholar
• Shamsi F. Investigation of human cell response to covalently attached RADA16-I peptide on silicon surfaces. Colloids Surf B Biointerfaces. 2016;145:470–478. doi:10.1016/j.colsurfb.2016.05.030
   PubMed Web of Science ®Google Scholar
• Wu D, Zhang S, Zhao Y, et al. The effects of motif net charge and amphiphilicity on the self-assembly of functionally designer RADA16-I peptides. Biomed Mater. 2018;13(3):035011. doi:10.1088/1748-605X/aab2fd
   PubMed Web of Science ®Google Scholar
• Taghavi L, Aramvash A, Seyedkarimi MS, et al. Evaluation of the hemocompatibility of RADA 16-I peptide. J Biomater Appl. 2018;32(8):1024–1031. doi:10.1177/0885328217748861
   PubMedGoogle Scholar
• Liu J, Zhang L, Yang Z, et al. Controlled release of paclitaxel from a self-assembling peptide hydrogel formed in situ and antitumor study in vitro. Int J Nanomedicine. 2011;6:2643–2653. doi:10.2147/IJN.S24038
   Web of Science ®Google Scholar
• Wei W, Meng C, Wang Y, et al. The interaction between self - assembling peptides and emodin and the controlled release of emodin from in-situ hydrogel. Artif Cells Nanomed and Biotechnol. 2019;47(1):3961–3975. doi:10.1080/21691401.2019.1673768
   PubMed Web of Science ®Google Scholar
• Meng C, Wei W, Wang Y, et al. Study on the interaction between self-assembling peptide and mangiferin and in vitro release of mangiferin from in-situ hydrogel. Int J Nanomedicine. 2019;14:7447–7460. doi:10.2147/IJN.S208267
   PubMed Web of Science ®Google Scholar
• Saini A, Serrano K, Koss K, et al. Evaluation of the hemocompatibility and rapid hemostasis of (RADA)4 peptide-based hydrogels. Acta Biomater. 2016;31:71–79. doi:10.1016/j.actbio.2015.11.059
   PubMedGoogle Scholar
• Mittal P, Vardhan H, Ajmal G, et al. Formulation, optimization, hemocompatibility and pharmacokinetic evaluation of PLGA nanoparticles containing paclitaxel. Drug Develop Communicat. 2019;45(3):365–378. doi:10.1080/03639045.2018.1542706
   Google Scholar
• Haag SL, Bernards MT. Enhanced biocompatibility of polyampholyte hydrogels. Langmuir. 2020;36(13):3292–3299. doi:10.1021/acs.langmuir.0c00114
   PubMedGoogle Scholar
• Naahidi S, Wang Y, Zhang M, et al. Evaluation of biocompatibility of the AC8 peptide and its potential use as a drug carrier. Mol Pharm. 2014;11(10):3409–3420. doi:10.1021/mp5001185
   PubMedGoogle Scholar
• Zhang F, Lu G, Wen X, et al. Magnetic nanoparticles coated with polyphenols for spatio-temporally controlled cancer photothermal/immunotherapy. J Control Release. 2020;326:131–139. doi:10.1016/j.jconrel.2020.06.015
   PubMed Web of Science ®Google Scholar
• Cheng Y, Jiao X, Fan W, et al. Controllable synthesis of versatile mesoporous organosilica nanoparticles as precision cancer theranostics. Biomaterials. 2020;256:120191. doi:10.1016/j.biomaterials.2020.120191
   PubMed Web of Science ®Google Scholar
• Ma Q, Ding Y, Wu Z, et al. Antitumor effects of emodin in Caco-2 human colon carcinoma cells are mediated via apoptosis, cell cycle arrest and downregulation of PI3K/AKT signalling pathway. J BUON. 2018;23(3):587–591.
   PubMedGoogle Scholar
• Trybus W, Król T, Trybus E, et al. Emodin induces death in human cervical cancer cells through mitotic catastrophe. Anticancer Res. 2019;39(2):679–686. doi:10.21873/anticanres.13163
   PubMedGoogle Scholar